Stamford, CT -- (SBWIRE) -- 10/28/2013 -- High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. Our Penny Stock Newsletter will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Today’s stocks to watch are: MELA Sciences Inc (NASDAQ:MELA), MannKind Corporation (NASDAQ:MNKD), Morgan Stanley (NYSE:MS), Advanced Cell Technology, Inc. (OTCMKTS:ACTC)
MELA Sciences Inc (NASDAQ:MELA) ended higher -10.11% and complete the day at $0.890. The total number of shares changed hands during the day was 1.06 million. After opening at $1.04, the stock hit as high as $1.04. However, it traded between $0.65 and $3.19 over the last twelve months. MELA Sciences, Inc., a medical device company, designs, develops, and commercializes a non-invasive point-of-care instrument to aid in the detection of melanoma.
Has MELA Found The Bottom and Ready To Move Up? Find Out Here
MannKind Corporation (NASDAQ:MNKD) closed yesterday at $5.32, a -2.47% decrease. Around 3.70 million shares were traded, beating an-average trading volume of 5.00 million shares. The company is now valued at around $1.61 billion. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate includes AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia.
Has MNKD Found The Bottom And Ready To Gain Momentum? Find Out Here
Morgan Stanley (NYSE:MS) moved -0.54 percent higher at $29.23 and traded between $29.15 and $29.41 after opening the day at $29.33. Its performance over the last five days remained -1.55%, which stands at +7.94% for a month. Going back further than one month, 1-year performance after recent close was +50.88%. Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals worldwide.
Why Should Investors Buy MS After the Recent Fall? Just Go Here and Find Out
Advanced Cell Technology, Inc. (OTCMKTS:ACTC)’s shares rose, +1.80 percent to close at $0.0622. The stock is up around +1.67% this year and -11.27% for the last 12 months. Around 5.28 million shares changed hands yesterday, lower from an-average trading volume of 6.50 million shares. Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine.
Why Should Investors Buy ACTC After The Recent Gain? Just Go Here and Find Out
High Rising Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to.We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)